Visual and Refractive Outcomes Following Implantation of an Enhanced Monofocal IOL: Real-World Outcomes
CLOSE
MENU

Visual and Refractive Outcomes Following Implantation of an Enhanced Monofocal IOL: Real-World Outcomes


Content provided by Bausch + Lomb Global Medical and Scientific Affairs.

Visual and Refractive Outcomes Following Implantation of an Enhanced Monofocal IOL: Real-World Outcomes


Content provided by Bausch + Lomb Global Medical and Scientific Affairs.

Summary

Purpose: Evaluating visual and refractive outcomes after bilateral Aspire intraocular lens (IOL) implantation.

Methods: Cataract patients ≥22 years with corrected distance visual acuity (CDVA) of 20/40 or worse and a projected CDVA of 20/30 or better received Aspire IOLs bilaterally (toric/non-toric). Binocular uncorrected, corrected, and distance-corrected visual acuities at far and intermediate (UDVA, UIVA, CDVA, DCIVA) were evaluated.

Results: With a mean postoperative MRSE of -0.18±0.37 D, Aspire IOL-implanted patients (n=310) achieved mean binocular UDVA and UIVA of 0.02±0.10 and 0.20±0.15 logMAR, respectively. Most subjects (90.6%) had binocular UDVA of 20/25 or better and 70.9% of subjects had UIVA of 20/32 or better. Mean binocular CDVA and DCIVA were -0.03±0.07 and 0.23±0.16 logMAR, respectively, with DCIVA of 20/32 or better in 64.4% of patients.

Conclusion: Bilateral implantation of Aspire IOL yielded good distance and intermediate visual acuity.

For More Information:

Get Support

Contact Us

Contact a
Representative

Find My Local Rep link-out icon

Submit a
Medical Inquiry

Complete the Form